phone-icon(+035) 527-1710-70
email-icongoogle@gmail.com
map-iconChoose an address
Eastgate Biotech Eastgate Biotech
  • Home
  • About Us
    • Management
  • Technology
    • Research
    • Intraoral Insulin
  • Products
  • Investors
    • Press Releases
    • SEC Filings
  • Media
    • Dr. Luc Duchesne
    • Investor Intel
    • Investor Wired
    • StockHouse
    • TechSonian
    • PharmaLot
  • Contact Us
Menu
Eastgate Biotech Eastgate Biotech
  • NEWSLETTER
  • CONTACT US
  • FAQs
  • SPECIAL OFFER
  • PURCHASE THEME

Press Releases

09 Mar
Uncategorized

EASTGATE BIOTECH CORPORATION AND AC NOVA TECHNOLOGIES (ATI PHARMA) ANNOUNCE A JOINT VENTURE

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
WEST CALDWELL, NJ and TORONTO, April 4, 2017 (MarketNewswire/-) EastGate Biotech Corp. (PinkSheets: ETBI-http://finance.yahoo.com/q...

Continue reading

09 Mar
Uncategorized

Pharmaceutical Biotech Research Company EastGate Biotech Corporation and AC Nova Technologies (ATI Pharma) Announce a Joint Venture to Commercialize Evidence-Based Natural Therapies Focused on Glucose Balance and Cardiovascular Health

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
WEST CALDWELL, NJ and TORONTO, ON--(Marketwired - Apr 4, 2017) - EastGate Biotech Corp. ( OTC PINK : ETBI ), an emerging pharmaceutic...

Continue reading

09 Mar
Uncategorized

Purchase and Sale Agreement to acquire Omni Surgery and Anti-Aging Centre

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
Purchase terms include implementation of Franchise Plan across all markets WEST CALDWELL, NJ and TORONTO, March 13, 2017 (MarketNews...

Continue reading

09 Mar
Uncategorized

EASTGATE BIOTECH FEATURED ON UPTICK NEWSWIRE

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
WEST CALDWELL, NJ and TORONTO, July 11, 2016 (GlobeNewsire/-) EastGate Biotech Corp. (Pink Sheets: ETBI), an emerging pharmaceutica...

Continue reading

09 Mar
Uncategorized

EASTGATE BIOTECH ANNOUNCES THAT IT HAS RECEIVED A SUBSTANTIAL ORDER FOR GLUCORA, ITS NATURAL GLUCOSE MANAGEMENT PRODUCT

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
West Caldwell, NJ and Toronto, May 2, 2016 (GlobeNewswire/-) EastGate Biotech Corp. (PinkSheets: ETBI), an emerging pharmaceutic...

Continue reading

09 Mar
Uncategorized

Eastgate Biotech CEO Anna Gluskin talks to ‘TheStockRadio.com’ about their products and delivery technology

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
Eastgate Biotech CEO Anna Gluskin talks to ‘TheStockRadio.com’ about their products and delivery technology   WEST CALDW...

Continue reading

09 Mar
Uncategorized

EastGate Patent for Lorazopem

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
EASTGATE BIOTECH RECEIVES NOTICE OF PUBLICATION FROM THE US PATENT AND TRADEMARK OFFICE FOR TWO PATENTS FOR THE COMPANY’S PROPRIETARY I...

Continue reading

09 Mar
Uncategorized

Do You Really Need An Antibiotic?

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
According to one study 20 percent of people who received a prescription antibiotic asked for it. It’s often a foolish request for a col...

Continue reading

09 Mar
Uncategorized

uti-e-drops-order-2

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
EASTGATE BIOTECH RECEIVES REPEAT PURCHASE ORDER FROM ITS CANADIAN DISTRIBUTOR SALT LAKE CITY and TORONTO,  January 5, 2016 (Mark...

Continue reading

09 Mar
Uncategorized

EASTGATE BIOTECH ANNOUNCES THE COMMENCEMENT OF SCALE-UP MANUFACTURING ACTIVITIES FOR ITS PROPRIETARY INTRAORAL INSULIN TABLET

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
SALT LAKE CITY, UT and TORONTO, ON--(Marketwired – September 29, 2015) - EastGate Biotech Corp. (OTC PINK:ETBI), an emerging pharma...

Continue reading

  • «
  • ‹
  • 4
  • 5
  • 6
  • 7
  • 8
  • ›
  • »

EastGate Biotech produces and distributes innovative and healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body.

2203-65 Harbour Square Toronto, Ontario M5J 2L4 Canada
Phone: +1 647 692 0652
WhatsApp: +1 647 692 0652
Our Office
  • New York
  • London SF
  • Cockfosters BP
  • Los Angeles
  • Chicago
  • Las Vegas
Innovative Alternatives to Conventional Pharmaceuticals.
  • Home
  • About Us
    • Management
  • Technology
    • Research
    • Intraoral Insulin
  • Products
  • Investors
    • Press Releases
    • SEC Filings
  • Media
    • Dr. Luc Duchesne
    • Investor Intel
    • Investor Wired
    • StockHouse
    • TechSonian
    • PharmaLot
  • Contact Us
  • Compare